Quick Details
- Processing Time:-
- Port:-
- Supply Ability: -
- Brand Name:Synpeptide
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
This medication is designed to improve glycemic control in people with type 2 diabetes by
targeting both the GIP and GLP-1 receptors. By stimulating these receptors, tirzepatide can increase insulin secretion and decrease glucagon secretion in a glucose-dependent manner, helping to
lower blood sugar levels.
Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight
in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with
diabetes
NOTE: This product was prepared by chemical synthesis. Used only for research. Not for human
use.
